Plerixafor is a hematopoietic stem cell (HSC) mobilizer that inhibits the CXCR4 chemokine receptor and blocks binding of its ligand, stromal cell-derived factor-1-α (SDF-1-α). This agent was approved on Dec. 15, 2008, as treatment in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize HSCs to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM).
Payment
eBioChem Escrow service is especially designed for online transaction. You, as a buyer, will pay the Supplier ONLY after you receive the item(s) and are satisfied with the item(s). This value-added service is absolutely FREE and is available for all transactions at eBioChem.com.
Payment Method
Alipay:
Alipay can support the domestic Union pay card with RMB payment
payPal:
Credit Card:
Paypal can support all of the foreign credit card payment
